Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.HemaSphere. 2022; 6: e732
- Iron absorption and loading in beta-thalassaemia intermedia.Lancet. 1979; 2: 819-821
- The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation.Blood. 2000; 95: 2975-2982
- Non-transferrin-bound iron transporters.Free Radic Biol Med. 2019; 133: 101-111
- SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis.Cell Metab. 2015; 22: 138-150
- The plasma membrane metal-ion transporter ZIP14 contributes to non-transferrin-bound iron uptake by human beta cells.Am J Physiol Cell Physiol. 2016; 312: C169-C175
- Tissue Distribution and Clearance Kinetics of Non-Transferrin-Bound Iron in the Hypotransferrinemic Mouse: A Rodent Model for Hemochromatosis.Proc Natl Acad Sci. 1987; 84: 3457-3461
- Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.Sci Rep. 2019; 9: 20234
- High nontransferrin bound iron levels and heart disease in thalassemia major.Am J Hematol. 2009; 84: 29-33
- No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia.Haematol-hematol J. 2008; 93: 1095-1096
- Hepatotoxicity of Iron Overload: Mechanisms of Iron-Induced Hepatic Fibrogenesis.Semin Liver Dis. 2005; 25: 433-449
- Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron.Blood. 2017; 130: 245-257
- Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients.Infect Immun. 2018; 86: e00253-e00318
- Severe bacterial infection in transfusion-dependent patients with thalassemia major.Clin Infectdis. 2003; 37: 984-988
- Infections and thalassaemia.Lancet Infect Dis. 2006; 6: 226-233
- Iron homeostasis: An anthropocentric perspective.J Biol Chem. 2017; 292: 12727-12734
- Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.Blood. 2018; 131: 899-910
- Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.Science. 2004; 306: 2090-2093
- Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions.Dev Dyn. 2022; 251: 26-46
- Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice.Hepatology. 2019; 70: 1986-2002
- IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.J Clininvest. 2004; 113: 1271-1276
- STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.Gastroenterology. 2007; 132: 294-300
- STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation.Blood. 2007; 109: 353-358
- Interleukin-6 induces hepcidin expression through STAT3.Blood. 2006; 108: 3204-3209
- Regulators of iron balance in humans.Blood. 1994; 84: 1697-1702
- Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.Haematologica. 2010; 95: 505-508
- Suppression of hepcidin during anemia requires erythropoietic activity.Blood. 2006; 108: 3730-3735
- Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.Physiol Res. 2006; 55: 667-674
- Urinary hepcidin in congenital chronic anemias.PediatrBlood Cancer. 2007; 48: 57-63
- Liver iron concentrations and urinary hepcidin in beta-thalassemia.Haematologica. 2007; 92: 583-588
- The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.Haematologica. 2006; 91: 809-812
- Hepcidin and iron-loading anemias.Haematologica. 2006; 91: 727-732
- Hepcidin in iron overload disorders.Blood. 2005; 105: 4103-4105
- Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.Blood. 2007; 109: 5027-5035
- Exploring the Role of Hepcidin, an Antimicrobial and Iron Regulatory Peptide, in Increased Iron Absorption in {beta}-Thalassemia.Ann New York Acad Sci. 2005; 1054: 417-422
- Decreased hepcidin mRNA expression in thalassemic mice.Br J Haematol. 2004; 124: 123-124
- A case of congenital dyserythropoietic anemia type 1 in a Japanese adult with a CDAN1 gene mutation and an inappropriately low serum hepcidin-25 level.Intern Med. 2012; 51: 917-920
- Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.J Molmed(berl). 2011; 89: 811-816
- Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.Blood. 2008; 112: 5241-5244
- High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.Nat Med. 2007; 13: 1096-1101
- Identification of erythroferrone as an erythroid regulator of iron metabolism.Nat Genet. 2014; 46: 678-684
- Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice.Physiol Rep. 2018; 6: e13890
- Erythroferrone inhibits the induction of hepcidin by BMP6.Blood. 2018; 132: 1473-1477
- Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3.Blood. 2020; 135: 453-456
- Immunoassay for human serum erythroferrone.Blood. 2017; 130: 1243-1246
- Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia.Blood. 2015; 126: 2031-2037
- Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis.Haematologica. 2018; 103: 1616-1626
- Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.Hepatology. 2011; 53: 1333-1341
- Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice.Hepatology. 2011; 54: 273-284
- Implication of the proprotein convertases in iron homeostasis: proprotein convertase 7 sheds human transferrin receptor 1 and furin activates hepcidin.Hepatology. 2013; 57: 2514-2524
- Soluble Transferrin Receptor-1 Levels in Mice Do Not Affect Iron Absorption.Acta Haematol. 2006; 116: 249-254
- Mice are poor heme absorbers and do not require intestinal Hmox1 for dietary heme iron assimilation.Haematologica. 2015; 100: e334-e337
- Hepatic hepcidin/intestinal HIF-2alpha axis maintains iron absorption during iron deficiency and overload.J Clin Invest. 2019; 129: 336-348
- Intestinal HIF2alpha promotes tissue-iron accumulation in disorders of iron overload with anemia.Proc Natl Acad Sci U S A. 2013; 110: E4922-E4930
- Ferritin is secreted via 2 distinct nonclassical vesicular pathways.Blood. 2018; 131: 342-352
- Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway.Blood. 2010; 116: 1574-1584
- Iron overload in beta-thalassemia intermedia: an emerging concern.Curr Opin Hematol. 2013; 20: 187-192
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
